Safety Evaluation of Prismocitrate 18 in Patients Receiving CRRT

NCT05399537 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Regional Citrate Anticoagulation (RCA)
Continuous Renal Replacement Therapy (CRRT)
Acute Kidney Injury (AKI)

Interventions

DRUG: Prismocitrate 18
DEVICE: PrisMax System Version 3.x with calcium line accessory

Sponsor

Vantive Health LLC

Collaborators

[object Object]